Our condition-specific, clinician-led CareTeams assess and educate patients to help ensure optimal drug adherence, persistency and safety. Our support for patients includes:
*Based on the availability of CVS/pharmacy locations and subject to applicable laws and regulations.
Let CVS Caremark Specialty Pharmacy get your patients started on treatment today.
Treating SLE: Benlysta® (Human Genome Sciences/ GlaxoSmithKline), was approved by the U.S. Food and Drug Administration (FDA) on March 10, 2011, for the treatment of active, autoantibody-positive systemic lupus erythematosus (SLE). SLE or "lupus" is a chronic autoimmune disease in which the body's own immune system attacks and destroys healthy tissue.
Please contact your CareTeam for more information.